Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 24, 2021JAMAOpen Access

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

Thomas A. Wadden
Thomas A. WaddenUniversity of PennsylvaniaTBTimothy S. BaileyEli Lilly (United States)LBLiana K. BillingsNorthShore University HealthSystem

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wadden et al. (2021) studied this question.

synapsesocial.com/papers/6a7d08423575152c8237cc3dhttps://doi.org/10.1001/jama.2021.1831
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?2019 · 258 citations
  2. 22013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults2013 · 2,758 citations
  3. 3Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes2012 · 760 citations
  4. 4Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 52020 · 284 citations